Jun Katagi

DEMONSTRATION OF DOCOSAHEXAENOIC ACID AS A BIOAVAILABILITY ENHANCER FOR CYP3A SUBSTRATES: IN VITRO AND IN VIVO EVIDENCE USING CYCLOSPORIN IN RATS

Vilasinee Hirunpanich, Jun Katagi, Benjabhorn Sethabouppha et al. · Drug Metabolism and Disposition · 2005 · 40 citations

Coactivation of secretogranin-II and BDNF genes mediated by calcium signals in mouse cerebellar granule cells

Yasutaka Fujita, Jun Katagi, Akiko Tabuchi et al. · Molecular Brain Research · 1999 · 25 citations

Molecular Neuroscience, Signal Transduction, Molecular Physiology +10

Comparative study of the zebrafish embryonic toxicity test and mouse embryonic stem cell test to screen developmental toxicity of human pharmaceutical drugs

Atsuto Inoue, Yuhei Nishimura, Norihito Matsumoto et al. · Fundamental Toxicological Sciences · 2016 · 20 citations · Full text

Toxicology Testing, Embryology, Chemical Compounds +16

Why Can dl-Sotalol Prolong the QT Interval In Vivo Despite Its Weak Inhibitory Effect on hERG K+ Channels In Vitro? Electrophysiological and Pharmacokinetic Analysis with the Halothane-Anesthetized Guinea Pig Model

Jun Katagi, Yuji Nakamura, Xin Cao et al. · Cardiovascular Toxicology · 2015 · 14 citations

Medicine, Physiology, Pharmacotherapy +9

Utility of human hepatocyte spheroids for evaluation of hepatotoxicity

Takuo Ogihara, Hisakazu Iwai, Yukiko Inoue et al. · Fundamental Toxicological Sciences · 2015 · 14 citations · Full text

Pathology, Pharmacotherapy, Pharmacological Study +16